BACKGROUND: Microsporidia are obligate intracellular parasites causing severe infections with lethal outcome in immunocompromised hosts. However, these pathogens are more frequently reported as latent infections in immunocompetent individuals and raises questions about the potential risk of reactivation following induced immunosuppression. AIMS: To evaluate the possibility latent microsporidiosis, efficacy or albendazole, and reactivation, the authors monitored the course of E. cuniculi infection in immunocompetent BALB/c mice and immunodeficient SCID mice using molecular methods. METHODS: Mice were per orally infected with 10(7) spores of E. cuniculi. Selected groups were treated with albendazole, re-infected or chemically immunosuppressed by dexamethasone. The presence of microsporidia in the host's organs and feces were determined using PCR methods. Changes in numbers of lymphocytes in blood and in spleen after induction of immunosuppression were confirmed using flow cytometry analysis. RESULTS: Whereas E. cuniculi caused lethal microsporidiosis in SCID mice, the infection in BABL/c mice remained asymptomatic despite parasite dissemination into many organs during the acute infection phase. Albendazole treatment led to microsporidia elimination from organs in BALB/c mice. In SCID mice, however, only a temporary reduction in number of affected organs was observed and infection re-established post-treatment. Dexamethasone treatment resulted in a chronic microsporidia infection disseminating into most organs in BALB/c mice. Although the presence of E. cuniculi in organs of albendazole- treated mice was undetectable by PCR, it was striking that infection was reactivated by immunosuppression treatment. CONCLUSION: Our results demonstrated that microsporidia can successfully survive in organs of immunocompetent hosts and are able to reactivate from undetectable levels and spread within these hosts after induction of immunosuppression. These findings stress the danger of latent microsporidiosis as a life-threatening risk factor especially for individuals undergoing chemotherapy and in transplant recipients of organs originating from infected donors.

Institute of Parasitology Biology Centre of Academy of Sciences of Czech Republic v v i Ceské Budejovice Czech Republic

Zobrazit více v PubMed

Canning EU, Lom J, Dyková I (1986) The microsporidia of vertebrates. Academic Press, London, 289 pp.

Cotte L, Rabodonirina M, Chapuis F, Bailly F, Bissuel F, et al. (1999) Waterborne outbreak of intestinal microsporidiosis in persons with and without human immunodeficiency virus infection. J Infect Dis 180: 2003–2008. PubMed

Dowd S, Gerba S, Pepper I (1998) Confirmation of the human pathogenic Microsporidia PubMed PMC

Fournier S, Liguory O, Santillana-Hayat M, Guillot E, Sarfati C, et al. (2000) Detection of microsporidia in surface water: a one-year follow-up study. FEMS Immunol Med Microbiol 29: 95–100. PubMed

Sinski E (2003) Environmental contamination with protozoan parasite infective stages: biology and risk assessment. Acta Microbiol Pol 52: 97–107. PubMed

Bryan RT, Schwartz DA (1999) Epidemiology of microsporidiosis.

Deplazes P, Mathis A, Weber R (2000) Epidemiology and zoonotic aspects of microsporidia of mammals and birds. Contrib Microbiol 6: 236–260. PubMed

Matsubayashi H, Koike I, Mikata I, Takei H, Higiwara S (1959) A case of PubMed

Canning EU, Hollister WS (1992) Human infections with microsporidia. Rev Med Microbiol 2: 35–42.

Weber R, Deplazes P, Flepp M, Mathis A, Baumann R, et al. (1997) Cerebral microsporidiosis due to PubMed

Wright JH, Craighead EM (1922) Infectious motor paralysis in young rabbits. J Exp Med 36: 135–140. PubMed PMC

Levaditi C, Nicolau S, Schoen R (1923) Etiology of epizootic rabbit encephalitis in reports with experimental studies of encephalitis lethargica.

Shadduck JA (1969) PubMed

Didier ES (1995) Reactive nitrogen intermediates implicated in the inhibition of PubMed

Didier ES, Snowden KF, Shadduck JA (1998) Biology of microsporidian species infecting mammals. Adv Parasitol 40: 283–320. PubMed

Mertens RB, Didier ES, Fishbein MC, Bertucci DC, Rogers LB, et al. (1997) PubMed

Weber R, Bryan RT, Schwartz DA, Owen RL (1994) Human microsporidial infections. Clin Microbiol Rev 7: 426–461. PubMed PMC

Didier ES (2005) Microsporidiosis: an emerging and opportunistic infection in humans and animals. Acta Trop 94: 61–76. PubMed

Pozio E, Morales MA (2005) The impact of HIV-protease inhibitors on opportunistic parasites. Trends Parasitol 21: 58–63. PubMed

Gannon J (1980) The course of infection of PubMed

Koudela B, Vítovec J, Kučerová Z, Ditrich O, Trávníček J (1993) The severe combined immunodeficient mouse as model for PubMed

Schmidt EC, Shadduck JA (1983) Murine encephalitozoonosis model for studying the host-parasite relationship of chronic infection. Infect Immun 40: 936–942. PubMed PMC

Waywa D, Kongkriengdaj S, Chaidatch S, Tiengrim S, Kowadisaiburana B, et al. (2001) Protozoan enteric infection in AIDS-related diarrhea in Thailand. Southeast Asian J Trop Med Public Health 32: 151–155. PubMed

Canning EU, Hollister WS (1991) PubMed

De Groote MA, Visvesvara G, Wilson ML, Pieniazek NJ, Slemenda SB, et al. (1995) Polymerase chain reaction and culture confirmation of disseminated PubMed

Koudela B, Lom J, Vítovec J, Kučerová Z, Ditrich O, et al. (1994) In vivo efficacy of albendazole against PubMed

De Bosscuere H, Wang Z, Orlandi PA (2007) First diagnosis of PubMed

Katzwinkel-Wladarsch S, Lieb M, Helse W, Löscher T, Rinder H (1996) Direct amplification and species determination of microsporidian DNA from stool specimens. Trop Med Int Health 1: 373–378. PubMed

Jalovecká M, Sak B, Kváč M, Květoňová D, Kučerová Z, et al. (2010) Activation of protective cell-mediated immune response in gastric mucosa during PubMed

Didier ES, Stovall ME, Green LC, Brindley PJ, Sestak K, et al. (2004) Epidemiology of microsporidiosis: sources and modes of transmission. Vet Par 126: 145–166. PubMed

Mathis A, Weber R, Deplazes P (2005) Zoonotic potential of the microsporidia. Clin Microbiol Rev 18: 423–445. PubMed PMC

Orenstein JM (1991) Microsporidiosis in the acquired immunodeficiency syndrome. J Parasitol 77: 843–864. PubMed

Franzen C, Hartmann P, Salzberger B (2005) Cytokine and nitric oxide responses of monocyte-derived human macrophages to microsporidian spores. Exp Parasitol 109: 1–6. PubMed

Khan IA, Moretto M, Weiss LM (2001) Immune response to PubMed PMC

Valencakova A, Halanova M (2012) Immune response to Encephalitozoon infection review. Comp Immunol Microbiol Infect Dis 35: 1–7. PubMed

Braunfuchsová P, Salát J, Kopecký J (2001) CD8+ T-lymphocytes protect SCID mice against PubMed

Khan IA, Schwartzman JD, Kasper LH, Moretto M (1999) CD8+ CTLs are essential for protective immunity against PubMed

Moretto M, Casciotti L, Durell B, Khan IA (2000) Lack of CD4(+) T-cells does not affect induction of CD8(+) T-cell immunity against PubMed PMC

Didier ES, Shadduck JA (1994) IFN-γ and LPS induce murine macrophages to kill PubMed

Sak B, Salát J, Horká H, Saková K, Ditrich O (2006) Antibodies enhance the protective effect of CD4+ T-lymphocytes in SCID mice p.o. infected with PubMed

Salát J, Horká H, Sak B, Kopecký J (2006) Pure CD4+ T-lymphocytes fail to protect perorally infected SCID mice from lethal microsporidiosis caused by PubMed

Sak B, Brady D, Pelikánová M, Květoňová D, Rost M, et al. (2011) Unapparent microsporidial infection among immunocompetent humans in the Czech Republic. J Clin Microbiol 49: 1064–1070. PubMed PMC

Sak B, Kváč M, Kučerová Z, Květoňová D, Saková K (2011) Latent microsporidial infection in immunocompetent individuals - a longitudinal study. PLoS Negl Trop Dis 5: e1162. PubMed PMC

Kakrania R, Joseph J, Vaddavalli PK, Gangopadhyay N, Sharma S (2006) Microsporidia keratoconjunctivitis in a corneal graft. Eye (Lond) 20: 1314–1315. PubMed

Ditrich O, Chrdle A, Sak B, Chmelík V, Kubále J, et al. (2011) PubMed PMC

Anete Lallo M, Porta Miche Hirschfeld M (2012) Encephalitozoonosis in pharmacologically immunosuppressed mice. Exp Parasitol 131: 339–343. PubMed

Hollister WS, Canning EU, Willcox A (1991) Evidence for widespread occurrence of antibodies to PubMed

Van Gool T, Vetter JCM, Weinmayr B, Van Dam A, Derouin F, et al. (1997) High seroprevalence of PubMed

Breitenmoser A, Mathis A, Bürgi E, Weber R, Deplazes P (1999) High prevalence of PubMed

Sak B, Kašičková D, Kváč M, Květoňová D, Ditrich O (2010) Microsporidia in exotic birds: intermittent spore excretion of Encephalitozoon spp. in naturally infected budgerigars ( PubMed

Encephalitozoon cuniculi Microsporidia in Cerebrospinal Fluid from Immunocompetent Patients, Czech Republic

Microsporidia (Encephalitozoon cuniculi) in Patients with Degenerative Hip and Knee Disease, Czech Republic

Chronic Infections in Mammals Due to Microsporidia

Comparison of the Concentration of Encephalitozoon cuniculi Genotypes I and III in Inflammatory Foci Under Experimental Conditions

Sparse Evidence for Giardia intestinalis, Cryptosporidium spp. and Microsporidia Infections in Humans, Domesticated Animals and Wild Nonhuman Primates Sharing a Farm-Forest Mosaic Landscape in Western Uganda

Encephalitozoon cuniculi Genotype II Concentrates in Inflammation Foci

Encephalitozoon cuniculi Genotype III Evinces a Resistance to Albendazole Treatment in both Immunodeficient and Immunocompetent Mice

Diversity of microsporidia, Cryptosporidium and Giardia in mountain gorillas (Gorilla beringei beringei) in Volcanoes National Park, Rwanda

Prevalence and diversity of Encephalitozoon spp. and Enterocytozoon bieneusi in wild boars (Sus scrofa) in Central Europe

Long-term monitoring of microsporidia, Cryptosporidium and Giardia infections in western Lowland Gorillas (Gorilla gorilla gorilla) at different stages of habituation in Dzanga Sangha Protected Areas, Central African Republic